uniQure
formerly uniQure N.V.uniQure | A Global Leader in Gene Therapy
Amsterdam, Netherlands · Founded 1998
- Headquarters
- Amsterdam
- Employees
- 201–500
- Founded
- 1998
- Business Model
- B2B
- Website
- uniqure.com
- Last Round
- Venture RoundJul 2013
- Rounds
- 3
Indexed holds 4 funding rounds for this company. The full record is or through the API.
About
uniQure is a Dutch biopharmaceutical company that develops gene therapies, including FDA-approved Hemgenix for hemophilia B and Glybera.
Summary
uniQure is a Biotech company based in Amsterdam, Netherlands, founded in 1998. Its most recent funding was a Venture Round in Jul 2013.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Feb 2014
Sign up to see all 4 events
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/uniqure"><img src="https://indexed.vc/api/badge/company/uniqure" alt="uniQure on Indexed.vc" width="260" height="76" /></a>